CompoAtlas

Dr. SOSNOWSKI'S ECZEMAHERO®

Natural health product licensed in Canada

Other names
ECZEMAHERO®
Licence holder
ACF Biotech Canada Inc.
NPN or DIN-HM
80133988
Status
Active licence
Licence date
3 September 2024
Revision date
Not provided
Form
Crème
Route of administration
Topique
Application type
Officinale

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the source
(11bêta)-11,17,21-trihydroxy-prégn-4-ène-3,20-dione

Source : Hydrocortisone

1 %

Non-medicinal ingredients

Triglycéride caprylique/caprique, Poly(hydroxystéarate) de poly(glycéryl-6), Carbonate de propylène, Gomme de xanthane, Cire de la graine d'Helianthus annus (tournesol), Hectorite de stéaralkonium, dl-Camphre, Glycérine, Farine de graine d'Avena sativa (avoine), Cire de Carnauba, Eau, Poly(ricinoléate) de poly(glycéryle-6), Gelée Royale, Coco-caprylate/caprate, Céramide NP, Huile de feuilles d'Eucalyptus globulus, Huile de ricin hydrogénée, Extrait de cire de propolis, Acide caprylhydroxamique, Huile de ricin, Sulfate de magnésium

PopulationAgeQuantity per servingFrequency
Enfants, adolescents et adultesminimum: 2 yearsNot specifiedminimum: 3 Tous les jours ; maximum: 4 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Anti-itch. Anti-pruritic. For temporary relief of minor skin irritations, rashes, itching and redness (due to eczema, insect bites, poison ivy, poison oak, poison sumac, contact dermatitis (e.g. caused by soaps, detergents, cosmetics and/or jewellery), seborrheic dermatitis, and psoriasis).

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80133988

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line